Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar BG2388 (25.43) Submitted: 9/26/2012 5:49:15 PM : Outperform Start Price: $45.07 MRK Score: +1.44

Industry is holding up in a pull back

Featured Broker Partners


Advertisement